Oxygenta Pharmaceutical Limited (BOM:524636)

India · Delayed Price · Currency is INR

46.66

-1.66 (-3.44%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Manufacturing of Pharmaceutical Products	1.09B	396.42M	309.88M	605.25M	520.27M
Manufacturing of Pharmaceutical Products Growth	175.71%	27.93%	-48.80%	16.33%	279.03%
Total	1.09B	396.42M	309.88M	605.25M	520.27M
Total Growth	175.71%	27.93%	-48.80%	16.33%	279.03%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	1.09B	395.74M	309.88M	605.25M	520.27M
India Growth	175.83%	27.71%	-48.80%	16.33%	279.03%
Export	1.42M	679.00K	-	-	-
Export Growth	108.84%	-	-	-	-
Total	1.09B	396.42M	309.88M	605.25M	520.27M
Total Growth	175.71%	27.93%	-48.80%	16.33%	279.03%

Source: S&P Global Market Intelligence.